Robert Magnuson
Family Medicine · Colorado Springs, CONPI 1043276074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $941 and has fallen 61.8% since, to $359 in 2025.
Across 34 payments — averaging $68.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$256
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$242
- GSK$228
- Amarin Pharma, Inc.$195
- Amgen$185
- Novartis$131
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $256 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $242 |
| GSK | 3 | $228 |
| Amarin Pharma, Inc. | 2 | $195 |
| Amgen | 2 | $185 |
| Novartis | 2 | $131 |
| AstraZeneca | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Sanofi-aventis U.S. LLC | 1 | $114 |
| Janssen Scientific Affairs, LLC | 1 | $111 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $111 |
| Kowa Pharmaceuticals America, Inc. | 1 | $105 |
| Alkermes, Inc. | 1 | $99 |
| AbbVie | 1 | $96 |
| Edwards Lifesciences | 2 | $52 |
| Boston Scientific | 2 | $51 |
| Mannkind Corporation | 1 | $24 |
| Bayer | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Pfizer | 1 | $16 |
| Merck | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,340 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Colorado Springs
- Matthew YoungColorado Springs$270K
- Lawrence AndrewsColorado Springs$102K
- Elizabeth EricksonColorado Springs$31K
- Daniel RohwederColorado Springs$21K
- Gary TarshisColorado Springs$10K
- Jeremy BrownColorado Springs$8K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.